Warren Chow
Associate Director for Clinical Sciences, Chao Family Comprehensive Cancer Center, Research Centers and Institutes · University of California
Credentials: · · · ·
History
- Present
- Present
- 1989–1991
Medical Oncology
- 1986–1989
Internal Medicine
Research
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
New England Journal of Medicine · 2023 · 739 citations
NCCN Guidelines Insights: Bone Cancer, Version 2.2017
Journal of the National Comprehensive Cancer Network · 2017 · 239 citations
Cancer · 2014 · 166 citations
- GS
36 papers
33 papers
- LL
32 papers
29 papers
- SS
27 papers
- YY
26 papers
- RM
21 papers
- MT
19 papers
Grants
- 2005–2010
Phase 1/2 Study of Nelfinavir in Liposarcoma
Food and Drug Administration · R01
Contact PI · $741.5K · Beckman Research Institute/City of Hope
- 2006–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $66K · University of Southern California
Clinical trials
- 2010–2015
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2006
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Principal investigator · Terminated · Phase 1, Phase 2
City of Hope Medical Center
- 2013–2017
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Study chair · Terminated · Phase 2
Emerald Clinical Inc.
- 2011–2018
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
Study chair · Completed · Phase 2
Emerald Clinical Inc.